TWD 47.1
(-1.26%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 286.35 Million TWD | 28.89% |
2022 | 222.16 Million TWD | 15.32% |
2021 | 192.65 Million TWD | 57.94% |
2020 | 121.97 Million TWD | 57.33% |
2019 | 77.53 Million TWD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 21.61 Million TWD | -59.19% |
2024 Q2 | 21.7 Million TWD | 7.81% |
2023 Q2 | 92.53 Million TWD | 34.41% |
2023 Q4 | 52.96 Million TWD | -26.44% |
2023 FY | 286.35 Million TWD | 28.89% |
2023 Q1 | 68.85 Million TWD | 39.21% |
2023 Q3 | 71.99 Million TWD | -22.2% |
2022 Q3 | 56.54 Million TWD | 0.0% |
2022 FY | 222.16 Million TWD | 15.32% |
2022 Q4 | 49.45 Million TWD | -12.54% |
2021 FY | 192.65 Million TWD | 57.94% |
2020 FY | 121.97 Million TWD | 57.33% |
2019 FY | 77.53 Million TWD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Allied Biotech Corporation | 246.43 Million TWD | -16.195% |
Easywell Biomedicals, Inc. | 170.71 Million TWD | -67.733% |
TTY Biopharm Company Limited | 3.22 Billion TWD | 91.117% |
Synmosa Biopharma Corporation | 2.11 Billion TWD | 86.492% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 86.664% |
Center Laboratories, Inc. | 618.09 Million TWD | 53.672% |
Tien Liang BioTech Co., Ltd. | 286.14 Million TWD | -0.071% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 38.901% |
InnoPharmax Inc. | 17.45 Million TWD | -1540.322% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | -17.053% |
Excelsior Biopharma Inc. | 306.93 Million TWD | 6.705% |
DV Biomed Co., Ltd. | 764.27 Million TWD | 62.533% |
Foresee Pharmaceuticals Co., Ltd. | 113.97 Million TWD | -151.247% |
Handa Pharmaceuticals, Inc. | 1.1 Billion TWD | 74.086% |
UniPharma Co., Ltd. | 51.01 Million TWD | -461.296% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | 27.859% |
Alar Pharmaceuticals Inc. | 465.92 Million TWD | 38.541% |
Winston Medical Supply Co., Ltd. | 347.59 Million TWD | 17.62% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -48270.101% |
Bioray Biotech Co., Ltd | 77.65 Million TWD | -268.767% |
TSH Biopharm Corporation Limited | 399.89 Million TWD | 28.394% |